Positions

Overview

  • Ricardo Azziz is an internationally recognized physician, scientist, and executive who currently serves as CEO of the American Society for Reproductive Medicine, the largest multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine worldwide. Previously he served as Chief Officer, Academic Health & Hospital Affairs, and Director of the SUNY Hispanic Leadership Institute, the State University of New York (SUNY), the largest university system in the nation. Dr. Azziz previously also served as president of Georgia Health Sciences University and then founding president of Georgia Regents University, one of Georgia’s four comprehensive research-level universities. He also served as founding CEO of the Georgia Regents Health System, the state’s only public academic health center.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2021 Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology.  224:428-444.e8. 2021
    2021 Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology2021
    2020 Environmental Pollutant Benzo[a]pyrene Induces Recurrent Pregnancy Loss through Promoting Apoptosis and Suppressing Migration of Extravillous TrophoblastBioMed Research International.  2020. 2020
    2017 Genetic basis of eugonadal and hypogonadal female reproductive disorders 2017
    2016 Androgen excess: Investigations and management 2016
    2016 Stein and Leventhal: 80 years onAmerican Journal of Obstetrics and Gynecology.  214:247.e1-247.e11. 2016
    2014 Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness the coronary artery risk development in young adults women's study 2014
    2014 Artist's statement: ParanoiaAcademic Medicine.  89:549. 2014
    2014 What Is the Value and Role of Academic Medicine in the Life of Its University?Academic Medicine.  89:208-211. 2014
    2013 Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndromeBioMed Research International.  2013. 2013
    2011 Fifteen-year trend in the use of male reproductive surgery: Analysis of the healthcare cost and utilization project dataBJU International.  107:1118-1123. 2011
    2010 Association study of four key folliculogenesis genes in polycystic ovary syndromeBJOG: An International Journal of Obstetrics and Gynaecology.  117:756-760. 2010
    2009 ReplyAmerican Journal of Obstetrics and Gynecology.  201. 2009
    2008 Use of metformin in polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology.  199:596-609. 2008
    2008 Metformin Use in Polycystic Ovary Syndrome: Metabolic Benefits and Diabetes PreventionAmerican Journal of Medicine.  121. 2008
    2008 Diagnosing the diagnosis: Why we must standardize the defining features of polycystic ovary syndromeAnnals of Clinical Biochemistry.  45:3-5. 2008
    2007 Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sistersAmerican Journal of Obstetrics and Gynecology.  196:398.e1-398.e6. 2007
    2006 A twenty-first century research agenda for polycystic ovary syndromeBest Practice and Research: Clinical Endocrinology and Metabolism.  20:331-336. 2006
    2006 Diagnosis, epidemiology, and genetics of the polycystic ovary syndromeBest Practice and Research: Clinical Endocrinology and Metabolism.  20:193-205. 2006
    2006 PrefaceBest Practice and Research: Clinical Endocrinology and Metabolism.  20. 2006
    2004 The prevalence of androgen excess among patients with minimal unwanted hair growthAmerican Journal of Obstetrics and Gynecology.  191:1914-1920. 2004
    2001 Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology.  185:1381-1387. 2001
    2000 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter studyAmerican Journal of Obstetrics and Gynecology.  183:1468-1474. 2000
    1999 Prevalence of 3β-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excessAmerican Journal of Obstetrics and Gynecology.  181:596-600. 1999
    1995 Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic womenAmerican Journal of Obstetrics and Gynecology.  172:1251-1256. 1995
    1995 Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulationAmerican Journal of Obstetrics and Gynecology.  172:914-918. 1995
    1993 3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenismAmerican Journal of Obstetrics and Gynecology.  168:889-895. 1993
    1991 When is late-onset adrenal hyperplasia not late-onset adrenal hyperplasia? 1991
    1990 Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasiaAmerican Journal of Obstetrics and Gynecology.  162:633-638. 1990
    1988 Acute myometritis and chorioamnionitis during cesarean section of asymptomatic womenAmerican Journal of Obstetrics and Gynecology.  159:1137-1139. 1988

    Chapter

    Year Title Altmetric
    2018 Polycystic ovary syndrome.  59-69. 2018
    2015 Presidential and Academic Health Center Leadership within the Modern University: Opportunities and Challenges.  13-21. 2015
    2012 Androgen excess disorders.  682-704. 2012
    2007 Adrenocortical dysfunction in polycystic ovary syndrome.  288-315. 2007
    2005 Endocrinology of the ovary.  391-403. 2005

    Research Overview

  • Dr. Azziz’s biomedical research focuses on the study of reproductive endocrinology and androgen excess disorders, including hirsutism, PCOS, and non-classic adrenal hyperplasia. He has published over 500 original peer-reviewed articles, book chapters, and reviews, and is consistently ranked one of America’s Top Doctors. He previously served as Deputy Director of the Clinical & Translational Sciences Institute and Assistant Dean for Clinical and Translational Sciences at UCLA; and Director of the Center for Androgen-Related Disorders at Cedars-Sinai Medical Center, Los Angeles. He is the founder and serves as Senior Executive Director of the Androgen Excess & PCOS Society. Among other advisory capacities, he served on multiple NIH committees, chaired the US FDA Advisory Board on Reproductive Health Drugs, and served on the oversight committee for the California Institute for Regenerative Medicine.
  • Teaching Overview

  • Dr Azziz serves as Research Professor, Dept. of Health Policy, Management and Behavior, School pf Public Health, University at Albany-SUNY; Professor, Dept of Obstetrics & Gynecology, School of Medicine, The University of Alabama at Birmingham; Clinical Professor, Dept. of Obstetrics & Gynecology, David Geffen School of Medicine, UCLA; and Fellow, Rockefeller Institute for Government.
  • Education And Training

  • Georgetown University Medical Center Obstetrics & Gynecology, Residency
  • Johns Hopkins University School of Medicine Obstetrics & Gynecology, Postdoctoral Fellowship
  • Doctor of Medicine, Penn State College of Medicine/Penn State Milton S. Hershey Medical Center 1981
  • Full Name

  • Ricardo Azziz